# SOX12

## Overview
SOX12 is a gene that encodes the SRY-box transcription factor 12, a member of the SOXC group of transcription factors. This protein is characterized by a conserved high-mobility group (HMG) box domain, which facilitates DNA binding and plays a crucial role in regulating gene expression. The SOX12 protein also contains a transactivation domain (TAD) that contributes to its function as a transcriptional activator, although it is less potent compared to its homologs, SOX4 and SOX11. SOX12 is expressed in various tissues, including neural and mesenchymal tissues, and is involved in several cellular processes, including development and cancer progression. Its interactions with other proteins and nucleic acids, particularly in the context of cancer, underscore its potential as a therapeutic target (Dy2008The; Mondal2019An; Du2019SOX12).

## Structure
The SOX12 protein is a member of the SOXC group of transcription factors, characterized by a conserved high-mobility group (HMG) box domain that facilitates DNA binding. This domain is located in the N-terminal region and is crucial for the protein's role in regulating gene expression (Dy2008The; Mondal2019An). The HMG box domain consists of three alpha helices and is highly conserved, with more than 84% identity between human and mouse (Mondal2019An). 

SOX12 also contains a transactivation domain (TAD) located in the C-terminal region, which is involved in transcriptional activation. This domain is shorter compared to other Sox family members and includes three conserved phosphorylation sites that may modulate the protein's activity (Dy2008The). The TAD is composed of proline, serine, and acidic residues, typical of transcriptional activation domains (Dy2008The).

The protein is predominantly hydrophilic, as indicated by its negative GRAVY score, and is structurally stable due to a relatively high aliphatic index (Mondal2019An). SOX12 is expressed in various tissues, including neural tissue and mesenchyme in human embryos, and in adult tissues such as the brain, lung, and heart (Dy2008The).

## Function
SOX12 is a member of the SOXC group of transcription factors, which also includes SOX4 and SOX11. These proteins are involved in transcriptional regulation and are characterized by a highly conserved C-terminal region and an HMG box domain, which are crucial for their function (She2015SOX; Dy2008The). SOX12 is expressed in various tissues, including the brain, heart, and lung, and is co-expressed with SOX4 and SOX11 in neuronal and mesenchymal tissues (Dy2008The).

SOX12 functions as a transcriptional activator, although it is less potent than SOX4 and SOX11. It can activate certain reporter genes but with less efficiency, suggesting specific roles in cellular processes (Dy2008The). The protein's DNA-binding efficiency is lower compared to SOX4 and SOX11, potentially due to sequence variations outside the HMG box domain (Dy2008The). SOX12 may modulate the activity of other SOXC proteins by competing for DNA binding, acting as a competitive inhibitor in certain contexts (Dy2008The).

In healthy human cells, SOX12 is involved in gene regulation through DNA binding and potential interactions with other proteins, although its specific roles and mechanisms remain less understood compared to SOX4 and SOX11 (PenzoMéndez2010Critical).

## Clinical Significance
The SOX12 gene has been implicated in various cancers due to its role in promoting cell proliferation and metastasis. In colorectal cancer (CRC), elevated SOX12 expression is associated with poor prognosis, including shorter overall survival and higher relapse rates. SOX12 acts as an oncogene by promoting tumor growth and metastasis through the regulation of asparagine synthesis, involving key enzymes such as GLS, GOT2, and ASNS (Du2019SOX12). In gastric cancer (GC), SOX12 upregulates MMP7 and IGF1, enhancing metastatic potential and correlating with poor clinical outcomes (Du2019Sex).

In multiple myeloma (MM), SOX12 is overexpressed and contributes to tumor growth by enhancing the Wnt/β-catenin signaling pathway. Knockdown of SOX12 in MM cells reduces proliferation and increases apoptosis, suggesting its potential as a therapeutic target (Gao2020SOX12). SOX12 is also upregulated in other cancers, such as breast, ovarian, and sarcoma, where it is linked to poor patient survival. Its expression is associated with pathways like TNF/β-catenin and WNT signaling, indicating a significant role in cancer progression (Seok2021MultiOmics). These findings highlight the clinical significance of SOX12 in cancer and its potential as a prognostic marker and therapeutic target.

## Interactions
SOX12, a member of the SOXC subgroup of transcription factors, participates in various interactions with proteins and nucleic acids that influence its role in cancer progression and development. SOX12 can form a ternary complex with the transcription factor Brn2 and DNA, similar to SOX4, although it binds DNA less efficiently than SOX4 but more efficiently than SOX11 (Dy2008The). The DNA-binding efficiency of SOX12 is modulated by specific regions outside its HMG box domain, such as the C52 domain, whose deletion increases DNA-binding efficiency (Dy2008The).

In colorectal cancer, SOX12 is transactivated by hypoxia-inducible factor 1-alpha (HIF-1α), which binds directly to the SOX12 promoter, indicating a nucleic acid interaction. This interaction promotes the transcription of genes involved in asparagine synthesis, such as GLS, GOT2, and ASNS, which are crucial for cancer cell proliferation and metastasis (Du2019SOX12). Chromatin immunoprecipitation (ChIP) assays have confirmed the binding of SOX12 to the promoters of these genes, further supporting its role in regulating gene expression through direct nucleic acid interactions (Du2019SOX12). These interactions highlight the significance of SOX12 in cancer-related pathways and its potential as a therapeutic target.


## References


[1. (PenzoMéndez2010Critical) Alfredo I. Penzo-Méndez. Critical roles for soxc transcription factors in development and cancer. The International Journal of Biochemistry &amp; Cell Biology, 42(3):425–428, March 2010. URL: http://dx.doi.org/10.1016/j.biocel.2009.07.018, doi:10.1016/j.biocel.2009.07.018. This article has 114 citations.](https://doi.org/10.1016/j.biocel.2009.07.018)

[2. (Mondal2019An) Sunil Kanti Mondal and Madhab Kumar Sen. An in-silico characterization of sry-related hmg box c (soxc) in humans and mouse. Meta Gene, 19:235–245, February 2019. URL: http://dx.doi.org/10.1016/j.mgene.2018.12.012, doi:10.1016/j.mgene.2018.12.012. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mgene.2018.12.012)

[3. (Du2019Sex) Feng Du, Weibo Feng, Sheng Chen, Shengda Wu, Tianyu Cao, Ting Yuan, Dean Tian, Yongzhan Nie, Kaichun Wu, Daiming Fan, and Limin Xia. Sex determining region y-box 12 (sox12) promotes gastric cancer metastasis by upregulating mmp7 and igf1. Cancer Letters, 452:103–118, June 2019. URL: http://dx.doi.org/10.1016/j.canlet.2019.03.035, doi:10.1016/j.canlet.2019.03.035. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2019.03.035)

[4. (Gao2020SOX12) Ying Gao, Lan Li, Limin Hou, Ben Niu, Xingli Ru, and Ding Zhang. Sox12 promotes the growth of multiple myeloma cells by enhancing wnt/β-catenin signaling. Experimental Cell Research, 388(1):111814, March 2020. URL: http://dx.doi.org/10.1016/j.yexcr.2020.111814, doi:10.1016/j.yexcr.2020.111814. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2020.111814)

[5. (Dy2008The) Peter Dy, Alfredo Penzo-Méndez, Hongzhe Wang, Carlos E. Pedraza, Wendy B. Macklin, and Véronique Lefebvre. The three soxc proteins—sox4, sox11 and sox12—exhibit overlapping expression patterns and molecular properties. Nucleic Acids Research, 36(9):3101–3117, April 2008. URL: http://dx.doi.org/10.1093/nar/gkn162, doi:10.1093/nar/gkn162. This article has 184 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkn162)

[6. (She2015SOX) Zhen-Yu She and Wan-Xi Yang. Sox family transcription factors involved in diverse cellular events during development. European Journal of Cell Biology, 94(12):547–563, December 2015. URL: http://dx.doi.org/10.1016/j.ejcb.2015.08.002, doi:10.1016/j.ejcb.2015.08.002. This article has 125 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejcb.2015.08.002)

[7. (Du2019SOX12) Feng Du, Jie Chen, Hao Liu, Yanhui Cai, Tianyu Cao, Weili Han, Xiaofang Yi, Meirui Qian, Dean Tian, Yongzhan Nie, Kaichun Wu, Daiming Fan, and Limin Xia. Sox12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis. Cell Death &amp; Disease, March 2019. URL: http://dx.doi.org/10.1038/s41419-019-1481-9, doi:10.1038/s41419-019-1481-9. This article has 62 citations.](https://doi.org/10.1038/s41419-019-1481-9)

[8. (Seok2021MultiOmics) Jaekwon Seok, Minchan Gil, Ahmed Abdal Dayem, Subbroto Kumar Saha, and Ssang-Goo Cho. Multi-omics analysis of sox4, sox11, and sox12 expression and the associated pathways in human cancers. Journal of Personalized Medicine, 11(8):823, August 2021. URL: http://dx.doi.org/10.3390/jpm11080823, doi:10.3390/jpm11080823. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jpm11080823)